John Simard
Net Worth

Last updated:

What is John Simard net worth?

The estimated net worth of Mr. John Simard is at least $46,956,733 as of 3 Jan 2024. He owns shares worth $12,098,318 as insider, has earned $4,078,415 from insider trading and has received compensation worth at least $30,780,000 in XBiotech Inc..

What is the salary of John Simard?

Mr. John Simard salary is $3,420,000 per year as Founder, Pres, Chief Executive Officer & Chairman in XBiotech Inc..

How old is John Simard?

Mr. John Simard is 63 years old, born in 1962.

What stocks does John Simard currently own?

As insider, Mr. John Simard owns shares in one company:

Company Title Shares Price per share Total value
XBiotech Inc. (XBIT) Founder, Pres, Chief Executive Officer & Chairman 3,840,736 $3.15 $12,098,318

What does XBiotech Inc. do?

XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation, and True Human COVID-19 therapy for treating the COVID-19 mutant virus. The company was incorporated in 2005 and is headquartered in Austin, Texas.

XBIT logo
XBIT
XBiotech Inc.
$3.15

John Simard insider trading

XBiotech Inc.

Mr. John Simard has made 18 insider trades between 2016-2024, according to the Form 4 filled with the SEC. Most recently he purchased 2,470,355 units of XBIT stock worth $9,999,997 on 3 Jan 2024.

The largest trade he's ever made was exercising 2,470,355 units of XBIT stock on 3 Jan 2024. As of 3 Jan 2024 he still owns at least 3,840,736 units of XBIT stock.

Transaction Date Security Shares Price per share Total value Source
Purchase
Convertible Loan Agreement 2,470,355 $4.05 $9,999,997
Sale
Common Stock 21,125 $12.9 $272,534
Sale
Common Stock 10,875 $12.83 $139,526
Sale
Common Stock 18,000 $12.77 $229,932
Sale
Common Stock 39,286 $12.45 $489,111
Sale
Common Stock 10,714 $12.53 $134,257
Sale
Common Stock 14,218 $12.66 $180,057
Sale
Common Stock 23,681 $13.09 $309,866
Sale
Common Stock 19,684 $13.23 $260,498
Sale
Common Stock 18,558 $13.07 $242,460
Sale
Common Stock 16,396 $13.41 $219,805
Sale
Common Stock 6,263 $14.27 $89,367
Sale
Common Stock 29,890 $14.81 $442,790
Sale
Common Stock 11,418 $14.49 $165,413
Sale
Common Stock 9,892 $14.68 $145,224
Sale
Common Stock 19,669 $15.14 $297,749
Sale
Common Stock 16,860 $15.24 $256,913
Sale
Common Stock 13,471 $15.06 $202,914
Sale
Common Stock 50,000 N/A N/A
Option
Common Shares 500,000 $7.5 $3,750,000
Option
Stock options 500,000 $7.5 $3,750,000
Option
Stock Option 1,000,000 N/A N/A
Option
Stock Option 300,000 $7.45 $2,235,000
Option
Common Stock 50,000 N/A N/A
Option
Stock Option 50,000 N/A N/A
Option
Stock Option 75,000 N/A N/A
Option
Stock Option 240,000 N/A N/A
Option
Common Stock 240,000 N/A N/A
Option
Stock Option 50,000 N/A N/A

XBiotech key executives

XBiotech Inc. executives and other stock owners filed with the SEC:

  • Dr. Sushma Shivaswamy (47) Chief Scientific Officer
  • Mr. John Simard (63) Founder, Pres, Chief Executive Officer & Chairman
  • Ms. Queena Han CPA, B.A., CPA, C.G.A. (58) Vice President of Fin. & HR and Sec.